Literature DB >> 22280235

Oral tolerance induction for human food allergy.

Geunwoong Noh1, Jae Ho Lee.   

Abstract

Food allergies are classified as IgE-mediated and non-IgE mediated type. The number of successful reports of immunotherapy, namely tolerance induction for food allergy (TIFA) are increasing, bringing hope for meaningful positive and radical treatment of food allergy. Therapeutic characteristics of the clinical course in TIFA for NFA are different from TIFA for IFA. Cytokines including IL-10, TGF-β and IFN-γ and regulatory cells such as Treg and Breg, are involved in immune tolerance. IFN-γ has been used for tolerance induction of food allergy as an immunomodulatory biologics. A definitive distinction between IgE-mediated and non-IgE-mediated food allergies is absolutely essential for diagnostic and therapeutic purposes. Original SOTI using IFN-γ is more effective then conventional SOTI without IFN-γ. Especially, IFN-γ is absolutely necessary for the tolerance induction of NFA. This review highlights and updates the advances in the conceptual immunological background and the clinical characteristics of oral tolerance induction for food allergy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22280235     DOI: 10.2174/187152812800392869

Source DB:  PubMed          Journal:  Inflamm Allergy Drug Targets        ISSN: 1871-5281


  4 in total

1.  Genotype-dependent effects of TGF-β1 on mast cell function: targeting the Stat5 pathway.

Authors:  Josephine Fernando; Travis W Faber; Nicholas A Pullen; Yves T Falanga; Elizabeth Motunrayo Kolawole; Carole A Oskeritzian; Brian O Barnstein; Geethani Bandara; Geqiang Li; Lawrence B Schwartz; Sarah Spiegel; David B Straus; Daniel H Conrad; Kevin D Bunting; John J Ryan
Journal:  J Immunol       Date:  2013-09-25       Impact factor: 5.422

2.  Regulatory T cells and the control of the allergic response.

Authors:  Ana Agua-Doce; Luis Graca
Journal:  J Allergy (Cairo)       Date:  2012-09-29

3.  Clostridium butyricum in combination with specific immunotherapy converts antigen-specific B cells to regulatory B cells in asthmatic patients.

Authors:  Hong-Ying Liao; Li Tao; Jian Zhao; Jie Qin; Gu-Cheng Zeng; Song-Wang Cai; Yun Li; Jian Zhang; Hui-Guo Chen
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

4.  Interleukin-13 suppresses interleukin-10 via inhibiting A20 in peripheral B cells of patients with food allergy.

Authors:  Ming-Yang Li; Min Zhu; En-Qiang Linghu; Fan Feng; Bing Zhu; Cheng Wu; Ming-Zhou Guo
Journal:  Oncotarget       Date:  2016-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.